Colchicine effects in patients with sepsis
Phase 3
Recruiting
- Conditions
- Sepsis.Symptoms and signs specifically associated with systemic inflammation and infection
- Registration Number
- IRCT20231017059748N1
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 44
Inclusion Criteria
1- Sepsis patients 2 - Aged 18 to 80 years 3 - High CRP3 at baseline 4 - Consented patients
Exclusion Criteria
1- Hypersensitivity to colchicine or other components of the formulation, 2- Hepatic failure (Child-Puff score B and C), 3- Renal failure (eGFR <15 mL/min/1.73 m2), 4- Malignancy, 5- Pregnancy, 6- Breastfeeding 7- Concomitant use of fusidic acid- lasmiditan- nirmatrelvir- pacritinib- fexinidazole.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method